Get started
Author

Hongryull Pyo

Observed names: H Pyo, H. Pyo, H.R. Pyo, HongRyull Pyo, Hongryull PYO
Observed institutions: Vanderbilt University, Samsung Medical Center, University of Surrey, National Cancer Center, Vanderbilt-Ingram Cancer Center, National Cancer Center Hospital, Samsung Biomedical Research Institute, Sungkyunkwan University, Vanderbilt University Medical Center
ORCID: 0000-0002-8064-3772
Observed ORCIDs: 0000-0002-8064-3772, 0000-0001-8404-7890, 0009-0002-7379-1109
OpenAlex ID: A5075677192
A selective cyclooxygenase-2 inhibitor, NS-398, enhances the effect of radiation in vitro and in vivo preferentially on the cells that express cyclooxygenase-2.
2001 · H Pyo, H Choy, et al. · PubMed · 185
Real world data of durvalumab consolidation after chemoradiotherapy in stage III non-small-cell lung cancer
2020 · Hyun Ae Jung, Jae Myoung Noh, et al. · Lung Cancer · 136
Phase III trial of concurrent thoracic radiotherapy with either first- or third-cycle chemotherapy for limited-disease small-cell lung cancer
2013 · J.-M. Sun, Y.C. Ahn, et al. · Annals of Oncology · 107
PDF
Radiosensitivity Enhancement by Celecoxib, a Cyclooxygenase (COX)-2 Selective Inhibitor, via COX-2–Dependent Cell Cycle Regulation on Human Cancer Cells Expressing Differential COX-2 Levels
2005 · You Keun Shin, Ji Sun Park, et al. · Cancer Research · 103
PDF
Treatment-Related Pneumonitis and Acute Esophagitis in Non–Small-Cell Lung Cancer Patients Treated With Chemotherapy and Helical Tomotherapy
2010 · Chang Hoon Song, Hongryull Pyo, et al. · International Journal of Radiation Oncology*Biology*Physics · 82
Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy
2020 · Nalee Kim, Jae Myoung Noh, et al. · Radiotherapy and Oncology · 76
Cyclooxygenase-independent down-regulation of multidrug resistance–associated protein-1 expression by celecoxib in human lung cancer cells
2005 · He-Kyung Kang, Eunmyong Lee, et al. · Molecular Cancer Therapeutics · 76
PDF
Preliminary result of definitive radiotherapy in patients with non-small cell lung cancer who have underlying idiopathic pulmonary fibrosis: comparison between X-ray and proton therapy
2019 · Hakyoung Kim, Hongryull Pyo, et al. · Radiation Oncology · 65
PDF
Potentially curative stereotactic body radiation therapy (SBRT) for single or oligometastasis to the lung
2012 · Dongryul Oh, Yong Chan Ahn, et al. · Acta Oncologica · 59
PDF
Prognostic Impact of Sarcopenia and Skeletal Muscle Loss During Neoadjuvant Chemoradiotherapy in Esophageal Cancer
2020 · Han Gyul Yoon, Dongryul Oh, et al. · Cancers · 58
PDF
Intensity-modulated radiotherapy with a belly board for rectal cancer
2006 · Joo Young Kim, Dae Yong Kim, et al. · International Journal of Colorectal Disease · 50
EGFR Mutation Is Associated with Short Progression-Free Survival in Patients with Stage III Non-squamous Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
2018 · Song Ee Park, Jae Myoung Noh, et al. · Cancer Research and Treatment · 45
PDF
Gefitinib radiosensitizes non-small cell lung cancer cells through inhibition of ataxia telangiectasia mutated
2010 · Soo-Yeon Park, Young Mee Kim, et al. · Molecular Cancer · 44
PDF
Randomized Phase II Trial Comparing Chemoradiotherapy with Chemotherapy for Completely Resected Unsuspected N2-Positive Non–Small Cell Lung Cancer
2017 · Jong-Mu Sun, Jae Myung Noh, et al. · Journal of Thoracic Oncology · 42
PDF
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
2008 · Won Park, Young Taek Oh, et al. · Journal of Experimental & Clinical Cancer Research · 39
PDF
Radiosensitivity Enhancement by Combined Treatment of Celecoxib and Gefitinib on Human Lung Cancer Cells
2006 · Ji Sun Park, Hyun Jung Jun, et al. · Clinical Cancer Research · 35
PDF
Neoadjuvant Nivolumab Plus Gemcitabine/Cisplatin Chemotherapy in Muscle-Invasive Urothelial Carcinoma of the Bladder
2022 · Hongsik Kim, Byong Chang Jeong, et al. · Cancer Research and Treatment · 31
PDF
Involvement of inducible nitric oxide synthase in radiation-induced vascular endothelial damage
2013 · C.-W. Hong, Y.-M. Kim, et al. · Journal of Radiation Research · 31
PDF
The novel taxane analogs, BMS-184476 and BMS-188797, potentiate the effects of radiation therapy in vitro and in vivo against human lung cancer cells
2001 · Jae-Sung Kim, George P Amorino, et al. · International Journal of Radiation Oncology*Biology*Physics · 30
Recurrence dynamics after trimodality therapy (Neoadjuvant concurrent chemoradiotherapy and surgery) in patients with stage IIIA (N2) lung cancer
2017 · Junghee Lee, Hong Kwan Kim, et al. · Lung Cancer · 29
Pretreatment Clinical Mediastinal Nodal Bulk and Extent do not Influence Survival in N2-Positive Stage IIIA Non-small Cell Lung Cancer Patients Treated with Trimodality Therapy
2014 · Hyebin Lee, Yong Chan Ahn, et al. · Annals of Surgical Oncology · 29
Impact Of Underlying Pulmonary Diseases On Treatment Outcomes In Early-Stage Non-Small Cell Lung Cancer Treated With Definitive Radiotherapy
2019 · Hakyoung Kim, Hongseok Yoo, et al. · International Journal of COPD · 26
PDF
Whole-Section Landscape Analysis of Molecular Subtypes in Curatively Resected Small Cell Lung Cancer: Clinicopathologic Features and Prognostic Significance
2023 · Soohyun Hwang, Tae Hee Hong, et al. · Modern Pathology · 25
PDF
Association of T Cell Senescence with Radiation Pneumonitis in Patients with Non-small Cell Lung Cancer
2022 · Kyung Hwan Kim, Hongryull Pyo, et al. · International Journal of Radiation Oncology*Biology*Physics · 23
Effect of Radiation Therapy Techniques on Outcome in N3-positive IIIB Non-small Cell Lung Cancer Treated with Concurrent Chemoradiotherapy
2015 · Jae Myoung Noh, Jin Man Kim, et al. · Cancer Research and Treatment · 23
PDF
Works count: 147
Citation count: 2,174
H-index: 23
I10-index: 61
Year
Topic
Type